BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
10 hedge funds and large institutions have $73.2K invested in Baudax Bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$59.8K | |
| 2 | +$3.42K | |
| 3 | +$455 | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$7 |
Top Sellers
| 1 | -$108K | |
| 2 | -$66K | |
| 3 | -$59K | |
| 4 |
VF
Virtu Financial
New York
|
-$27K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$16K |